Tuesday, June 08, 2021 7:32:10 PM
With years of extensive experience, Creative Biolabs now is proud to offer the in vitro immunization service for the customize antibodies production. As one of the most efficient immunization strategies, in vitro immunization plays an important role in the monoclonal antibody production.
Introduction of In Vitro Immunization
In the field of biological research, obtaining a high-affinity and high-selectivity antibody is essential for meeting the requirements in diagnostics and therapeutics. As one of the highest efficiency methods, in vitro immunization has taken a series of advantages to establishing the antibody with the desired selectivity and affinity against varies of antigens compared with the conventional immunization method. Through the in vitro immunization, the immune cells will be isolated from the naïve animals and stimulated with the antigen in vitro, this will then result in the induction of B-cells which have the ability to produce the antigen-specific antibodies for the further screening.
In Vitro Immunization-based Human Antibody Production
Creative Biolabs has developed a high-efficiency protocol to induce specific antigen immune response in human peripheral blood mononuclear cells (PBMCs) for the production of human mAbs on the basis of in vitro immunization. The PBMCs which directly isolated from human blood cannot show the sensitization to antigens because of the suppressed function from the immunosuppressive cells such as monocytes and NK cells. However, after the treatment with L-leucyl-L-leucine methyl ester (LLME), the PBMCs are able to initiate the immune response against any antigens as the immunosuppressive cells have been removed. After the in vitro immunization, the antigen-specific antibody genes can be isolated from the library with the help of varies display methods. Combined with our Native™ Human Antibody Discovery Service, Creative Biolabs is able to discovery antigen specific human antibodies with naïve pair heavy- and light-chain.
Features of In Vitro Immunization:
It can bypass ethical limitations to trigger B cells response to antigens of interest. Creative Biolabs can make use of human peripheral blood mononuclear cells to conduct in vitro immunization so that can harvest pure human-originated antibodies to contribute the research within the human body.
It can save the time for evaluating the immune response induced by any antigens during the vaccines test.
Compared to in vivo immunization, in vitro immunization does not have the influence of immunosuppressive and tolerance.
The amount of antigen required for in vitro immunization is greatly reduced.
As a pioneer and the undisputed global leader in the field of antibody production, Creative Biolabs has successfully applied our advanced in vitro immunization service. Depending on novel research methods and tools, we are capable of meeting the specific need of each customer with the best project design. If you are interested in our in vitro immunization service, please do not hesitate to inquire us for more details.
Recent ENZC News
- Small Cap Recipient of Military Drone Technology • InvestorsHub NewsWire • 11/20/2023 01:14:45 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM